EUCR
Eucrates Biomedical Acquisition Corp. Ordinary Shares
EUCR
EUCR
Delisted
EUCR was delisted on the 26th of April, 2023.
34 hedge funds and large institutions have $49.6M invested in Eucrates Biomedical Acquisition Corp. Ordinary Shares in 2021 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
34
Holders Change
+3
Holders Change %
+9.68%
% of All Funds
0.6%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
7
Reduced
5
Closed
3
Calls
$19K
Puts
–
Net Calls
+$19K
Net Calls Change
+$19K
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
SCM
26
Saba Capital Management
New York
| $263K | +$263K | +26,874 | New |
|
|
MF
27
Magnetar Financial
Evanston,
Illinois
| $206K | +$90.4K | +9,224 | +78% |
|
28
T. Rowe Price Associates
Baltimore,
Maryland
| $199K | – | – | – |
|
|
AC
29
Athanor Capital
New York
| $118K | -$7.45K | -760 | -6% |
|
|
DFCM
30
Dark Forest Capital Management
San Juan,
Puerto Rico
| $103K | +$103K | +10,509 | New |
|
31
Morgan Stanley
New York
| $38K | – | – | – |
|
32
UBS Group
Zurich,
Switzerland
| $24K | -$12.5K | -1,299 | -34% |
|
|
WCMNY
33
Westchester Capital Management (New York)
Valhalla,
New York
| $11K | +$11K | +1,100 | New |
|
|
CIM
34
Cowen Investment Management
New York
| $489 | – | – | – |
|
|
GPCM
35
Granite Point Capital Management
Boston,
Massachusetts
| – | -$985K | -100,000 | Closed |
|
|
EAM
36
Exos Asset Management
New York
| – | -$103K | -10,485 | Closed |
|
|
PAM
37
Panagora Asset Management
Boston,
Massachusetts
| – | -$98K | -9,922 | Closed |
|